Meng Zhou
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 5
- Hematology top 5%
- Iron Metabolism and Disorders 6
- Immunology top 10%
- Immunotherapy and Immune Responses 6
- Immune Cell Function and Interaction 4
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems 4
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 7
- PI3K/AKT/mTOR signaling in cancer 5
-
- MicroRNA in disease regulation 3
- Cited by
- BiomaterialsHematologyImmunology
- Journals
- Cell Death and Disease (3 papers)Advanced Functional Materials (2 papers)Immunology Letters (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Meng Zhou
43 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Biomaterials 450
- Hematology 314
- Immunology 415
- Pharmaceutical Science 90
- Molecular Biology 890
Countries citing papers authored by Meng Zhou
This map shows the geographic impact of Meng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Zhou more than expected).
Fields of papers citing papers by Meng Zhou
This network shows the impact of papers produced by Meng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Zhou. The network helps show where Meng Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meng Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2022 | 21 | |
| 5 | 2021 | 12 | |
| 6 | 2021 | 20 | |
| 7 | 2021 | 18 | |
| 8 | 2020 | 8 | |
| 9 | 2020 | 12 | |
| 10 | 2020 | 7 | |
| 11 | 2020 | 55 | |
| 12 | 2019 | 96 | |
| 13 | 2019 | 98 | |
| 14 | Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Gliomabreakdown → | 2018 | 315 |
| 15 | 2018 | 133 | |
| 16 | 2016 | 30 | |
| 17 | 2016 | 2 | |
| 18 | 2015 | 6 | |
| 19 | 2014 | 29 | |
| 20 | 2012 | 47 |
About Meng Zhou
Meng Zhou is a scholar working on Hematology, Immunology, Pharmaceutical Science, Cancer Research and Physiology, having authored 46 papers that have together received 1.9k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (7 papers), Immunotherapy and Immune Responses (6 papers), Iron Metabolism and Disorders (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Nanoparticle-Based Drug Delivery (5 papers), Advanced Drug Delivery Systems (4 papers), Immune Cell Function and Interaction (4 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Biomaterials (450 citations), Hematology (314 citations), Immunology (415 citations), Pharmaceutical Science (90 citations) and Molecular Biology (890 citations). Meng Zhou has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiyun Yan, Kelong Fan, Jing Feng, Minmin Liang, Demin Duan, Dongling Yang, Jiuyang He, Xiaohua Jia, Kun Wang and Jie Tian. Their work appears in journals such as Cell Death and Disease, Advanced Functional Materials, Immunology Letters, Journal of Experimental & Clinical Cancer Research and Annals of Vascular Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.